Therefore, even though DC-SIGN can confer protective regulatory immunity in a pre-clinical model for auto-immune disease (147), DC-SIGN signaling may be involved in the sensitization phase of allergic diseases as allergens are capable of DC activation via DC-SIGN binding (148). The gene discussed is CD209; the disease is allergic disease.